Afya (NASDAQ:AFYA) Upgraded by Citigroup to "Neutral" Rating

Key Points

• Afya has been upgraded by Citigroup from a "sell" rating to a "neutral" rating, with a target price of $14.00, indicating a potential upside of 1.23% from the stock's previous close.
• The stock currently has a consensus rating of "Hold" among analysts, with an average price target of $17.40.
• Institutional investors hold 88.02% of Afya's shares, with significant increases in holdings reported by firms like Goldman Sachs, which raised its position by 167.3% in the first quarter.

Afya (NASDAQ:AFYA - Get Free Report) was upgraded by Citigroup from a "sell" rating to a "neutral" rating in a report released on Tuesday, MarketBeat.com reports. The firm currently has a $14.00 target price on the stock, down from their previous target price of $16.00. Citigroup's price objective points to a potential upside of 2.34% from the company's previous close.

Several other research analysts have also recently weighed in on AFYA. UBS Group restated a "neutral" rating and set a $19.50 price target (up from $17.50) on shares of Afya in a report on Thursday, June 12th. Wall Street Zen cut shares of Afya from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Two analysts have rated the stock with a sell rating and four have issued a hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $17.40.

Afya Stock Performance

Shares of NASDAQ:AFYA traded down $0.02 on Tuesday, reaching $13.68. 133,427 shares of the company's stock were exchanged, compared to its average volume of 112,826. The company has a fifty day moving average of $16.90 and a 200-day moving average of $17.31. The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of 10.36, a PEG ratio of 0.49 and a beta of 0.58. Afya has a twelve month low of $13.47 and a twelve month high of $19.90. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.41.

Institutional Investors Weigh In On Afya

Several institutional investors have recently added to or reduced their stakes in AFYA. Doma Perpetual Capital Management LLC boosted its position in Afya by 4.4% during the 1st quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company's stock valued at $10,619,000 after buying an additional 25,111 shares during the period. Renaissance Technologies LLC grew its stake in shares of Afya by 14.0% during the 4th quarter. Renaissance Technologies LLC now owns 412,000 shares of the company's stock worth $6,543,000 after purchasing an additional 50,700 shares during the period. Perpetual Ltd raised its stake in Afya by 1.8% in the second quarter. Perpetual Ltd now owns 151,180 shares of the company's stock valued at $2,700,000 after buying an additional 2,730 shares in the last quarter. Carrera Capital Advisors acquired a new stake in shares of Afya in the second quarter valued at approximately $1,750,000. Finally, Lazard Asset Management LLC raised its stake in Afya by 54.3% during the 4th quarter. Lazard Asset Management LLC now owns 97,313 shares of the company's stock valued at $1,545,000 after acquiring an additional 34,246 shares during the last quarter. 88.02% of the stock is owned by hedge funds and other institutional investors.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.